Afya (AFYA) Stock Price Target 2026

The average analyst price target for Afya is $16.79, 56.9% above the current price. Of 6 analysts, 2 rate it Buy, 2 Hold and 2 Sell. Targets range from $12 to $23. The latest change came on Nov 3, 2026, when JP Morgan lowered its price target on Afya from $19 to $17.50 and kept an Overweight rating.

The Average Analyst Price Target for Afya is $16.79.

Price Target Range — 11 Quarters

Analyst Consensus — 6 Analysts

2Buy

2Hold

2Sell

Consensus RatingNeutral# Analysts6Avg. Consensus PT$16.79Upside to Avg. PT+56.9%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Afya Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 3, 2026	JP Morgan	Marcelo Santos	PT Cut	Overweight	$19→$18
Nov 3, 2026	Citigroup	Leandro Bastos	Upgrade	Neutral→Buy	$16→$12
Oct 7, 2026	JP Morgan	Marcelo Santos	Upgrade	Neutral→Overweight	$21→$19
Jun 22, 2026	JP Morgan	Marcelo Santos	PT Cut	Neutral	$22→$21
Apr 30, 2026	JP Morgan	Marcelo Santos	PT Cut	Neutral	$22→$22
Feb 24, 2026	B of A Securities	Roberto Otero	Downgrade	Buy→Neutral	$22→$17
Feb 13, 2026	Morgan Stanley	Mauricio Cepeda	Downgrade	Equal-Weight→Underweight	$18→$16
Jan 16, 2026	UBS	Andre Salles	Downgrade	Buy→Neutral	$18→$16
Jan 8, 2026	UBS	Andre Salles	PT Cut	Buy	$19→$18
Jan 7, 2026	JP Morgan	Marcelo Santos	Downgrade	Overweight→Neutral	$25→$22
Sep 8, 2025	UBS	Andre Salles	Upgrade	Neutral→Buy	$20→$19
Sep 8, 2025	JP Morgan	Marcelo Santos	Upgrade	Neutral→Overweight	$24→$25
Jul 29, 2025	Citigroup	Leandro Bastos	Upgrade	Sell→Neutral	$16→$14
Jun 12, 2025	UBS	Andre Salles	PT Raise	Neutral	$18→$20
Mar 11, 2025	Morgan Stanley	Mauricio Cepeda	Downgrade	Equal-Weight→Underweight	$19→$17
Jan 31, 2025	Citigroup	Leandro Bastos	Downgrade	Neutral→Sell	$18→$15
Jan 17, 2025	JP Morgan	Marcelo Santos	PT Cut	Neutral	$25→$21
Dec 3, 2024	Goldman Sachs	Gustavo Miele	Initiate	Sell	$16
Aug 30, 2024	UBS	Andre Salles	Initiate	Neutral	$20
Jun 21, 2024	Morgan Stanley	Mauricio Cepeda	PT Cut	Equal-Weight	$21→$19